ch.oddb.org
 
Apotheken | Doctor | Drugs | Hospital | Interactions | MiGeL | Registration owner | Services
Pfizer AG - Rapamune 1 mg, überzogene Tabletten
5580401
Rapamune 1 mgüberzogene Tabletten
L04AA10Sirolimus
14.12.2001  
Composition
sirolimusum 1 mg, poloxamerum 188, lactosum monohydricum 86.4 mg, macrogolum 8000, magnesii stearas, talcum, macrogolum 20'000, glyceroli mono-oleas, lacca, calcii sulfas anhydricus, cellulosum microcristallinum, saccharum 213.85 mg, E 171, povidonum K 29-32, int-rac-alpha-tocopherylis acetas, cera carnauba, Drucktinte: lacca, E 172 (rubrum), propylenglycolum, simeticonum, pro compresso obducto.
Packungsbestandteile
überzogene Tabletten 
 
Active AgentDose
Sirolimus1 mg
BAG: Active AgentDose
Sirolimus1 mg
 
Inactive agentsDoseadditional_information
(Rubrum)  
Calcii Sulfas Anhydricus  
Cellulosum Microcristallinum  
Cera Carnauba  
E 171 color.
E 172 color.
Glyceroli Mono-Oleas  
Int-Rac-Alpha-Tocopherylis Acetas  
Lacca Drucktinte
Lactose Monohydrate86.4 mg 
Macrogol20000  
Magnesii Stearas  
Poloxamer188  
Povidonum K29-32 
Pro Compresso Obducto  
Propylenglycol  
Saccharum213.85 mg 
Simeticone  
Talcum  
 
Package numberPackage SizeEFPCPCategorySLOut of trade (MedRef)
00130 Tablet(s)136.98165.40BSLYes
003100 Tablet(s)392.93443.75BSLYes
2025 ©ywesee GmbH
Settings | Help | FAQ | Login | Contact | Home